Evidence map›Paper›PMID 30393495›Full record

ArticleArchives of medical science : AMS2018

High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women.

Servet Altay, Altan Onat, Günay Can, Eyyup Tusun, Barış Şimşek, Adnan Kaya

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Servet AltayDepartment of Cardiology, Trakya University, Edirne, Turkey.
Altan OnatDepartment of Cardiology, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey.
Günay CanDepartment of Public Health, Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey.
Eyyup TusunDepartment of Cardiology, Sanliurfa Education and Research Hospital, Şanlıurfa, Turkey.
Barış ŞimşekDepartment of Cardiology, Siyami Ersek Center for Cardiovascular Surgery, Istanbul, Turkey.
Adnan KayaDepartment of Cardiology, Suruç State Hospital, Şanliurfa, Turkey.
Istanbul University · TRDr. Siyami Ersek Göğüs Kalp Ve Damar Cerrahisi Eğitim Ve Araştırma Hastanesi · TRŞanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi · TRSivas State Hospital · TRTrakya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of the study was to evaluate whether serum thyroid-stimulating hormone (TSH) within the normal range in euthyroid subjects (having normal free triiodothyronine (fT3) and thyroxine (fT4)) is related to the risk of overall mortality or a composite endpoint of death and nonfatal events. MATERIAL AND

methodsIn 614 middle-aged adult hospital screenees, free of uncontrolled diabetes at baseline, the association of sex-specific TSH tertiles with death was prospectively assessed using Cox regression, with the composite endpoint assessed using logistic regression in adjusted analyses, stratified by gender.

resultsIn total, 64 deaths and additional incident nonfatal events in 141 cases were recorded at a mean 7.55 years' follow-up. Multivariable linear regression revealed TSH to be significantly associated among men with age (

conclusionsThe significant association of higher range of normal serum TSH in euthyroid middle-aged adults with the risk of death and nonfatal adverse outcomes in women alone cannot be accounted for by the action of thyroid hormone and is consistent with involvement of TSH in the pro-inflammatory state.

Indexed as

cardiovascular eventseuthyroid statusmortalitypro-inflammatory statethyroid hormonesthyroid-stimulating hormone

Identifiers

PMID30393495
PMCPMC6209708
OpenAlexW2543587584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.